Replies to post #188657 on Biotech Values

[DewDiligence]

ENDP concedes in bidding war for SLXP:

http://finance.yahoo.com/news/endo-withdraws-proposal-salix-132300201.html

At ENDP's current share price, its stock + cash offer is worth less than VRX's $173/sh in cash.

[DewDiligence]

VRX selling $1.67B* of stock to help pay for SLXP buyout:

http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-offering-1-200100681.html

*Assuming exercise of underwriter’s option.